FAM162A-CSTA Fusion FISH Probe
The FAM162A-CSTA Fusion FISH Probe is used to confirm a fusion of the FAM162A and CSTA genes. The fusion of the FAM162A and CSTA genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FAM162A-CSTA-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FAM162A-CSTA-20-AQAQ | 20 (40 μL) | 200 μL |
|
CSTA Gene Summary
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins, and kininogens. This gene encodes a stefin that functions as a cysteine protease inhibitor, forming tight complexes with papain and the cathepsins B, H, and L. The protein is one of the precursor proteins of cornified cell envelope in keratinocytes and plays a role in epidermal development and maintenance. Stefins have been proposed as prognostic and diagnostic tools for cancer. [provided by RefSeq, Jul 2008]
Gene Name: Cystatin A
Chromosome: CHR3: 122044010 -122060815
Locus: 3q21.1
FAM162A Gene Summary
The Family With Sequence Similarity 162 Member A (FAM162A) gene is located on chr3 :122103022-122128961 at 3q21.1.
Gene Name: Family With Sequence Similarity 162 Member A
Chromosome: CHR3: 122103022 -122128961
Locus: 3q21.1
Gene Diseases
The FAM162A CSTA Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|